Parkman Healthcare Partners LLC

13F filer · CIK 0001777015

Reported Aug 14, 2026

Net seller this quarter

13F portfolio value$977MU.S. long equity reported on 13F

Positions7617 new · 30 closed

Net flow last quarter-$126MBuys minus sells

Top 10 positions weight33.5%Concentration

Holdings

13F · last 4 quarters free

Scroll for earlier quarters

Company	Value	% of portfolio	% of company	POSITION CHANGE qoq %	First reported
Q2 2026Reported Aug 14, 202676 positions
MBXMBX Biosciences, Inc.	$44.2M	4.52%	1.67%	0.0%	Q4 2024
LLYELI LILLY & Co	$42M	4.30%	0.00%	+1.1%	Q3 2022
CVSCVS HEALTH Corp	$40.5M	4.15%	0.03%	+1.2%	Q4 2021
DXCMDexcom Inc	$36M	3.69%	0.14%	-22.5%	Q4 2019
PTCTPTC Therapeutics, Inc.	$35.5M	3.64%	0.52%	+1.0%	Q3 2024
RCUSArcus Biosciences, Inc.	$28.3M	2.90%	0.72%	-23.9%	Q2 2020
GPCRStructure Therapeutics Inc.	$26.1M	2.67%	0.23%	+109.3%	Q3 2023
VRDNViridian Therapeutics, Inc.\DE	$25.3M	2.59%	1.22%	+146.9%	Q3 2022
AGIOAgios Pharmaceuticals, Inc.	$24.8M	2.54%	1.12%	+65.8%	Q4 2022
INBXInhibrx Biosciences, Inc.	$24.3M	2.49%	1.75%	New	Q2 2026
XENEXenon Pharmaceuticals Inc.	$24M	2.46%	0.41%	-20.1%	Q4 2019
EWTXEdgewise Therapeutics, Inc.	$23.4M	2.40%	0.54%	+78.7%	Q3 2022
UNHUnitedhealth Group Inc	$23.2M	2.38%	0.01%	Not reported	Q4 2019
SYKStryker Corp	$21.4M	2.19%	0.02%	-56.1%	Q3 2024
IQVIqvia Holdings Inc.	$20.4M	2.09%	0.06%	+22.0%	Q4 2019
ZBHZimmer Biomet Holdings, Inc.	$20M	2.05%	0.12%	-13.7%	Q4 2019
PODDInsulet Corp	$20M	2.05%	0.19%	-16.1%	Q2 2020
ASMBAssembly Biosciences, Inc.	$19.8M	2.03%	3.63%	+75.4%	Q3 2025
SNDXSyndax Pharmaceuticals Inc	$19.2M	1.96%	0.98%	-2.7%	Q2 2020
EYPTEyePoint, Inc.	$18.4M	1.89%	1.52%	-4.9%	Q4 2025
THCTenet Healthcare Corp	$18.2M	1.86%	0.11%	+94.1%	Q4 2021
LIVNLivaNova PLC	$17.3M	1.77%	0.38%	-47.9%	Q1 2024
ANIPAni Pharmaceuticals Inc	$16.8M	1.72%	0.90%	-27.7%	Q2 2021
BCRXBiocryst Pharmaceuticals Inc	$16.2M	1.66%	0.64%	-4.9%	Q4 2019
ALNYAlnylam Pharmaceuticals, Inc.	$15.3M	1.56%	0.04%	+88.3%	Q4 2019
INDVIndivior Pharmaceuticals, Inc.	$14.9M	1.53%	0.30%	New	Q2 2026
NVSTEnvista Holdings Corp	$14.6M	1.49%	0.34%	-22.2%	Q1 2026
DRUGBright Minds Biosciences Inc.	$14.4M	1.47%	2.69%	+411.4%	Q1 2026
XERSXeris Biopharma Holdings, Inc.	$14.3M	1.47%	1.04%	+5.0%	Q1 2024
AVTXAvalo Therapeutics, Inc.	$14.2M	1.45%	1.45%	New	Q2 2026
FDMT4D Molecular Therapeutics, Inc.	$12.6M	1.29%	1.72%	+81.4%	Q3 2025
IMNMImmunome Inc.	$12.6M	1.29%	0.52%	+47.3%	Q3 2025
STOKStoke Therapeutics, Inc.	$11.6M	1.19%	0.57%	+5.6%	Q3 2025
WATWaters Corp	$11.3M	1.16%	0.03%	+14.2%	Q2 2022
ANROAlto Neuroscience, Inc.	$11.3M	1.16%	1.22%	New	Q2 2026
ORKAOruka Therapeutics, Inc.	$10.8M	1.10%	0.19%	New	Q2 2026
ADPTAdaptive Biotechnologies Corp	$10.4M	1.07%	0.31%	-11.8%	Q4 2025
ABSIAbsci Corp	$10.4M	1.06%	0.57%	-52.0%	Q4 2025
MLYSMineralys Therapeutics, Inc.	$10.3M	1.05%	0.43%	+0.1%	Q1 2023
COGTCogent Biosciences, Inc.	$9.81M	1.00%	0.15%	+153.1%	Q2 2022
QUREuniQure N.V.	$9.59M	0.98%	0.30%	+0.6%	Q4 2024
TARSTarsus Pharmaceuticals, Inc.	$9.44M	0.97%	0.35%	New	Q2 2026
AMRXAmneal Pharmaceuticals, Inc.	$9.37M	0.96%	0.17%	+80.0%	Q1 2026
IRTCiRhythm Holdings, Inc.	$8M	0.82%	0.20%	+67.6%	Q3 2021
CYRXCryoport, Inc.	$7.98M	0.82%	1.00%	New	Q2 2026
BSXBoston Scientific Corp	$7.7M	0.79%	0.01%	-59.8%	Q4 2019
CLYMClimb Bio, Inc.	$7.35M	0.75%	0.98%	Not reported	Q3 2024
AMLXAmylyx Pharmaceuticals, Inc.	$7.16M	0.73%	0.36%	-35.8%	Q2 2025
UPBUpstream Bio, Inc.	$6.47M	0.66%	1.71%	+18.9%	Q1 2025
RMDResmed Inc	$6.43M	0.66%	0.02%	Not reported	Q1 2025

Q1 2026Reported May 15, 202689 positions
SYKStryker Corp	$50.9M	5.24%	0.04%	+46.7%	Q3 2024
DXCMDexcom Inc	$43.3M	4.47%	0.18%	+17.4%	Q4 2019
KALVKalVista Pharmaceuticals, Inc.	$36.9M	3.81%	3.58%	+3.8%	Q1 2025
PODDInsulet Corp	$32.9M	3.39%	0.22%	+11.2%	Q2 2020
LLYELI LILLY & Co	$31.8M	3.28%	0.00%	Not reported	Q3 2022
PTCTPTC Therapeutics, Inc.	$29.4M	3.03%	0.52%	+169.3%	Q3 2024
XENEXenon Pharmaceuticals Inc.	$28.9M	2.98%	0.51%	+222.4%	Q4 2019
BSXBoston Scientific Corp	$28.2M	2.90%	0.03%	-10.3%	Q4 2019
CVSCVS HEALTH Corp	$27.8M	2.87%	0.03%	-14.0%	Q4 2021
RCUSArcus Biosciences, Inc.	$26.1M	2.69%	0.96%	+24.6%	Q2 2020
LIVNLivaNova PLC	$25.7M	2.65%	0.74%	-1.7%	Q1 2024
ZBHZimmer Biomet Holdings, Inc.	$24.4M	2.51%	0.14%	+78.5%	Q4 2019
MBXMBX Biosciences, Inc.	$23.9M	2.46%	1.68%	-9.7%	Q4 2024
ANIPAni Pharmaceuticals Inc	$21.6M	2.23%	1.25%	+93.5%	Q2 2021
SNDXSyndax Pharmaceuticals Inc	$21.1M	2.17%	1.02%	+57.1%	Q2 2020
QGENQiagen N.V.	$20M	2.06%	0.23%	+1.1%	Q4 2023
NVSTEnvista Holdings Corp	$18.1M	1.86%	0.43%	New	Q1 2026
EYPTEyePoint, Inc.	$17.5M	1.80%	1.62%	+24.5%	Q4 2025
ABBVAbbVie Inc.	$16.3M	1.68%	0.00%	Not reported	Q2 2020
BCRXBiocryst Pharmaceuticals Inc	$16.3M	1.68%	0.67%	+89.8%	Q4 2019
IQVIqvia Holdings Inc.	$14.8M	1.52%	0.05%	+146.1%	Q4 2019
AGIOAgios Pharmaceuticals, Inc.	$13.7M	1.41%	0.68%	+305.1%	Q4 2022
ILMNIllumina, Inc.	$13.6M	1.40%	0.07%	New	Q1 2026
EWEdwards Lifesciences Corp	$13.4M	1.38%	0.03%	+10.7%	Q2 2020
NBIXNeurocrine Biosciences Inc	$13.1M	1.35%	0.10%	-13.6%	Q4 2019
KNSAKiniksa Pharmaceuticals International, plc	$12.5M	1.29%	Not reported	-61.0%	Q4 2020
ASMBAssembly Biosciences, Inc.	$11.4M	1.18%	2.59%	+64.9%	Q3 2025
GPCRStructure Therapeutics Inc.	$11.2M	1.15%	0.11%	+322.0%	Q3 2023
MCKMckesson Corp	$11M	1.13%	0.01%	-65.1%	Q4 2024
STOKStoke Therapeutics, Inc.	$11M	1.13%	0.54%	-21.8%	Q3 2025
VRDNViridian Therapeutics, Inc.\DE	$10.9M	1.13%	0.54%	-29.2%	Q3 2022
WAYWaystar Holding Corp.	$10.7M	1.10%	0.23%	+20.1%	Q2 2025
MLYSMineralys Therapeutics, Inc.	$10.3M	1.06%	0.46%	-7.3%	Q1 2023
EWTXEdgewise Therapeutics, Inc.	$10.2M	1.05%	0.30%	-24.5%	Q3 2022
XERSXeris Biopharma Holdings, Inc.	$9.98M	1.03%	1.00%	+1.8%	Q1 2024
THCTenet Healthcare Corp	$9.46M	0.98%	0.06%	-17.2%	Q4 2021
AORTArtivion, Inc.	$9.23M	0.95%	0.53%	+15.3%	Q1 2025
NUVLNuvalent, Inc.	$9.02M	0.93%	2.81%	-25.8%	Q4 2023
ATECAlphatec Holdings, Inc.	$8.96M	0.92%	0.54%	+197.2%	Q4 2019
ALNYAlnylam Pharmaceuticals, Inc.	$8.91M	0.92%	0.02%	-43.6%	Q4 2019
AXGNAxogen, Inc.	$8.88M	0.92%	0.50%	+7.1%	Q3 2020
IMNMImmunome Inc.	$8.82M	0.91%	0.36%	+45.2%	Q3 2025
AMLXAmylyx Pharmaceuticals, Inc.	$8.64M	0.89%	0.56%	+62.8%	Q2 2025
IDXXIdexx Laboratories Inc	$8.43M	0.87%	0.02%	Not reported	Q3 2020
WATWaters Corp	$7.88M	0.81%	0.03%	-36.9%	Q2 2022
ADPTAdaptive Biotechnologies Corp	$7.66M	0.79%	0.35%	+37.4%	Q4 2025
UPBUpstream Bio, Inc.	$7.08M	0.73%	1.45%	-5.7%	Q1 2025
ERASErasca, Inc.	$6.58M	0.68%	0.13%	New	Q1 2026
APGEApogee Therapeutics, Inc.	$6.54M	0.67%	0.10%	-40.3%	Q4 2024
COOCooper Companies, Inc.	$6.43M	0.66%	0.05%	-28.3%	Q1 2021

Q4 2025Reported Feb 17, 2026100 positions
BSXBoston Scientific Corp	$47.7M	4.54%	0.03%	+15.2%	Q4 2019
PODDInsulet Corp	$40M	3.81%	0.20%	+21.2%	Q2 2020
DXCMDexcom Inc	$39M	3.71%	0.15%	+242.3%	Q4 2019
SYKStryker Corp	$37.1M	3.53%	0.03%	+64.5%	Q3 2024
CVSCVS HEALTH Corp	$35.7M	3.40%	0.04%	+18.6%	Q4 2021
MCKMckesson Corp	$29.8M	2.84%	0.03%	+27.4%	Q4 2024
KALVKalVista Pharmaceuticals, Inc.	$28.6M	2.72%	3.47%	+1.9%	Q1 2025
MBXMBX Biosciences, Inc.	$27.9M	2.66%	1.97%	+14.5%	Q4 2024
KNSAKiniksa Pharmaceuticals International, plc	$27.4M	2.61%	Not reported	-1.0%	Q4 2020
MASIMasimo Corp	$26M	2.48%	0.37%	Not reported	Q3 2020
LIVNLivaNova PLC	$25.3M	2.41%	0.75%	+49.0%	Q1 2024
TERNTerns Pharmaceuticals, Inc.	$25.1M	2.39%	0.55%	-33.6%	Q1 2023
VRDNViridian Therapeutics, Inc.\DE	$24.5M	2.33%	0.77%	-31.7%	Q3 2022
RCUSArcus Biosciences, Inc.	$23.1M	2.20%	0.77%	+48.4%	Q2 2020
UPBUpstream Bio, Inc.	$22.7M	2.16%	1.54%	-1.1%	Q1 2025
QGENQiagen N.V.	$22.2M	2.12%	0.23%	-1.2%	Q4 2023
FOLDAmicus Therapeutics, Inc.	$21.2M	2.02%	0.48%	-11.9%	Q1 2024
EYPTEyePoint, Inc.	$19.9M	1.89%	1.31%	New	Q4 2025
ALNYAlnylam Pharmaceuticals, Inc.	$19M	1.81%	0.04%	-45.6%	Q4 2019
NBIXNeurocrine Biosciences Inc	$16.3M	1.55%	0.11%	-19.1%	Q4 2019
WATWaters Corp	$15.9M	1.51%	0.07%	Not reported	Q2 2022
MTDMettler Toledo International Inc/	$15.3M	1.46%	0.05%	Not reported	Q4 2023
MLYSMineralys Therapeutics, Inc.	$14.9M	1.42%	0.50%	-9.9%	Q1 2023
STOKStoke Therapeutics, Inc.	$13.7M	1.30%	0.73%	+72.1%	Q3 2025
AAgilent Technologies, Inc.	$13.6M	1.30%	0.04%	New	Q4 2025
ZBHZimmer Biomet Holdings, Inc.	$13.6M	1.29%	0.08%	-39.9%	Q4 2019
DHRDanaher Corp	$13.5M	1.28%	0.01%	-46.7%	Q2 2020
XERSXeris Biopharma Holdings, Inc.	$13.3M	1.26%	1.02%	-5.6%	Q1 2024
EWEdwards Lifesciences Corp	$12.9M	1.23%	0.03%	-3.1%	Q2 2020
PTCTPTC Therapeutics, Inc.	$12.2M	1.16%	0.20%	-20.9%	Q3 2024
WAYWaystar Holding Corp.	$12.1M	1.15%	0.19%	+20.6%	Q2 2025
SNDXSyndax Pharmaceuticals Inc	$12.1M	1.15%	0.66%	-32.2%	Q2 2020
THCTenet Healthcare Corp	$12M	1.14%	0.07%	-18.6%	Q4 2021
NUVLNuvalent, Inc.	$11.9M	1.14%	3.79%	-1.2%	Q4 2023
ANIPAni Pharmaceuticals Inc	$11.4M	1.09%	0.64%	Not reported	Q2 2021
EWTXEdgewise Therapeutics, Inc.	$10.6M	1.01%	0.40%	-22.3%	Q3 2022
UNHUnitedhealth Group Inc	$10.5M	1.00%	0.00%	Not reported	Q4 2019
COOCooper Companies, Inc.	$10.3M	0.98%	0.06%	-29.0%	Q1 2021
AORTArtivion, Inc.	$9.97M	0.95%	0.46%	-1.1%	Q1 2025
APGEApogee Therapeutics, Inc.	$9.82M	0.93%	0.19%	+22.9%	Q4 2024
MAZEMaze Therapeutics, Inc.	$8.67M	0.83%	0.42%	+4.6%	Q3 2025
ASMBAssembly Biosciences, Inc.	$8.48M	0.81%	1.57%	-0.7%	Q3 2025
ACLXArcellx, Inc.	$8.35M	0.80%	0.22%	-14.5%	Q2 2022
AXGNAxogen, Inc.	$8.19M	0.78%	0.53%	-50.1%	Q3 2020
IQVIqvia Holdings Inc.	$7.94M	0.76%	0.02%	+17.4%	Q4 2019
SIBNSI-BONE, Inc.	$7.38M	0.70%	0.86%	-1.1%	Q2 2023
DOCSDoximity, Inc.	$7.19M	0.68%	0.09%	-9.3%	Q1 2025
BCRXBiocryst Pharmaceuticals Inc	$7.02M	0.67%	0.42%	-11.1%	Q4 2019
XENEXenon Pharmaceuticals Inc.	$6.91M	0.66%	0.19%	-12.5%	Q4 2019
OPRXOptimizeRx Corp	$6.6M	0.63%	2.87%	+5.7%	Q1 2025

Q3 2025Reported Nov 14, 202590 positions
BSXBoston Scientific Corp	$42.4M	4.42%	0.03%	+53.4%	Q4 2019
ALNYAlnylam Pharmaceuticals, Inc.	$40M	4.17%	0.07%	-5.0%	Q4 2019
PODDInsulet Corp	$35.9M	3.74%	0.17%	+9.9%	Q2 2020
CVSCVS HEALTH Corp	$28.6M	2.98%	0.03%	-26.7%	Q4 2021
KNSAKiniksa Pharmaceuticals International, plc	$26.1M	2.72%	Not reported	+37.4%	Q4 2020
VRDNViridian Therapeutics, Inc.\DE	$24.9M	2.60%	1.40%	-11.1%	Q3 2022
ZBHZimmer Biomet Holdings, Inc.	$24.8M	2.58%	0.13%	+4.6%	Q4 2019
SYKStryker Corp	$23.7M	2.47%	0.02%	+27.3%	Q3 2024
QGENQiagen N.V.	$22.3M	2.33%	0.23%	+0.4%	Q4 2023
MCKMckesson Corp	$22M	2.30%	0.02%	+63.5%	Q4 2024
DHRDanaher Corp	$21.9M	2.29%	0.02%	+0.4%	Q2 2020
KALVKalVista Pharmaceuticals, Inc.	$21.1M	2.20%	3.43%	+155.5%	Q1 2025
QUREuniQure N.V.	$20.2M	2.10%	0.56%	-22.1%	Q4 2024
NBIXNeurocrine Biosciences Inc	$19.9M	2.08%	0.14%	-14.6%	Q4 2019
BIIBBiogen Inc.	$18.2M	1.90%	0.09%	Not reported	Q4 2022
MLYSMineralys Therapeutics, Inc.	$17.3M	1.80%	0.58%	-1.7%	Q1 2023
UPBUpstream Bio, Inc.	$15.9M	1.65%	1.56%	+17.9%	Q1 2025
THCTenet Healthcare Corp	$15.1M	1.57%	0.08%	-56.0%	Q4 2021
XERSXeris Biopharma Holdings, Inc.	$14.6M	1.52%	1.08%	-15.0%	Q1 2024
LIVNLivaNova PLC	$14.4M	1.51%	0.51%	+57.6%	Q1 2024
MBXMBX Biosciences, Inc.	$13.5M	1.41%	1.73%	-11.3%	Q4 2024
FOLDAmicus Therapeutics, Inc.	$13.3M	1.39%	0.55%	+177.2%	Q1 2024
DOCSDoximity, Inc.	$13.1M	1.37%	0.10%	+48.1%	Q1 2025
SNDXSyndax Pharmaceuticals Inc	$13M	1.36%	0.97%	-2.4%	Q2 2020
PTCTPTC Therapeutics, Inc.	$12.4M	1.30%	0.25%	+11.4%	Q3 2024
ACLXArcellx, Inc.	$12.3M	1.28%	0.26%	-14.0%	Q2 2022
EWEdwards Lifesciences Corp	$12.1M	1.26%	0.03%	-38.1%	Q2 2020
COOCooper Companies, Inc.	$12.1M	1.26%	0.09%	-54.2%	Q1 2021
WAYWaystar Holding Corp.	$11.6M	1.21%	0.18%	+118.6%	Q2 2025
DXCMDexcom Inc	$11.5M	1.20%	0.04%	-24.0%	Q4 2019
CSTLCastle Biosciences Inc	$10.8M	1.13%	1.63%	+35.0%	Q2 2020
OPRXOptimizeRx Corp	$10.4M	1.09%	2.74%	+0.4%	Q1 2025
NUVLNuvalent, Inc.	$10.4M	1.08%	3.84%	+0.5%	Q4 2023
ATECAlphatec Holdings, Inc.	$10.1M	1.06%	0.47%	+7.4%	Q4 2019
AORTArtivion, Inc.	$9.36M	0.98%	0.47%	+14.7%	Q1 2025
UTHRUNITED THERAPEUTICS Corp	$9.22M	0.96%	0.05%	+149.7%	Q1 2021
AXGNAxogen, Inc.	$8.95M	0.93%	1.09%	-25.6%	Q3 2020
EWTXEdgewise Therapeutics, Inc.	$8.92M	0.93%	0.52%	-15.0%	Q3 2022
RCUSArcus Biosciences, Inc.	$8.88M	0.93%	0.61%	+8.9%	Q2 2020
INCYIncyte Corp	$8.52M	0.89%	0.05%	+33.9%	Q2 2025
TVTXTravere Therapeutics, Inc.	$8.12M	0.85%	0.38%	-58.9%	Q2 2022
URGNUroGen Pharma Ltd.	$8.03M	0.84%	0.86%	+127.8%	Q3 2023
ASNDAscendis Pharma A/S	$8.02M	0.84%	0.07%	-4.2%	Q4 2019
AMLXAmylyx Pharmaceuticals, Inc.	$7.87M	0.82%	0.53%	-10.9%	Q2 2025
BCRXBiocryst Pharmaceuticals Inc	$7.69M	0.80%	0.48%	+0.5%	Q4 2019
VCYTVeracyte, Inc.	$7.66M	0.80%	0.28%	+1.2%	Q3 2021
LLYELI LILLY & Co	$7.63M	0.80%	0.00%	-70.0%	Q3 2022
QDELQuidelOrtho Corp	$7.45M	0.78%	0.37%	-34.6%	Q2 2020
XENEXenon Pharmaceuticals Inc.	$7.07M	0.74%	0.23%	+17.1%	Q4 2019
TERNTerns Pharmaceuticals, Inc.	$7.02M	0.73%	1.07%	+14.3%	Q1 2023

Premium opens every quarter this fund has filed